DE69531957D1 - Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung - Google Patents

Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung

Info

Publication number
DE69531957D1
DE69531957D1 DE69531957T DE69531957T DE69531957D1 DE 69531957 D1 DE69531957 D1 DE 69531957D1 DE 69531957 T DE69531957 T DE 69531957T DE 69531957 T DE69531957 T DE 69531957T DE 69531957 D1 DE69531957 D1 DE 69531957D1
Authority
DE
Germany
Prior art keywords
production
sustained
granular preparations
release
plasticizer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69531957T
Other languages
English (en)
Other versions
DE69531957T2 (de
Inventor
Hiroaki Nakagami
Masazumi Kojima
Shinji Sagasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of DE69531957D1 publication Critical patent/DE69531957D1/de
Application granted granted Critical
Publication of DE69531957T2 publication Critical patent/DE69531957T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69531957T 1994-12-19 1995-12-18 Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung Expired - Lifetime DE69531957T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP31441494 1994-12-19
JP31441494 1994-12-19
PCT/JP1995/002594 WO1996019200A1 (fr) 1994-12-19 1995-12-18 Preparation granulaire a liberation prolongee et procede de production

Publications (2)

Publication Number Publication Date
DE69531957D1 true DE69531957D1 (de) 2003-11-20
DE69531957T2 DE69531957T2 (de) 2004-08-12

Family

ID=18053063

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69531957T Expired - Lifetime DE69531957T2 (de) 1994-12-19 1995-12-18 Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung

Country Status (14)

Country Link
US (2) US5858411A (de)
EP (1) EP0797987B1 (de)
JP (1) JP3893439B2 (de)
KR (1) KR100424931B1 (de)
CN (1) CN1093758C (de)
AT (1) ATE251896T1 (de)
DE (1) DE69531957T2 (de)
DK (1) DK0797987T3 (de)
ES (1) ES2210321T3 (de)
FI (1) FI119720B (de)
NO (1) NO320356B1 (de)
PT (1) PT797987E (de)
TW (1) TW406022B (de)
WO (1) WO1996019200A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
DE69837903T2 (de) * 1997-08-11 2008-02-14 Pfizer Products Inc., Groton Feste pharmazeutische Dispersionen mit erhöhter Bioverfügbarkeit
US6632455B2 (en) * 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
DE19820801A1 (de) * 1998-05-09 1999-11-25 Gruenenthal Gmbh Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
DE59907889D1 (de) * 1998-09-30 2004-01-08 Basf Ag Verwendung von wasserlöslichen oder wasserdispergierbaren polyether-haltigen pfropfpolymerisaten als überzugsmittel, bindemittel und/oder filmbildender hilfsstoff in pharmazeutischen darreichungsformen
ATE400251T1 (de) * 1999-02-09 2008-07-15 Pfizer Prod Inc Zusammensetzungen basischer arzneistoffe mit verbesserter bioverfügbarkeit
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
GB0003782D0 (en) * 2000-02-17 2000-04-05 Dumex Ltd As Process
JP4310605B2 (ja) * 2001-05-25 2009-08-12 大塚製薬株式会社 医薬用組成物
US20090214644A1 (en) * 2003-07-31 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations with reduced adverse effects
US20050025825A1 (en) * 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US20050245614A1 (en) * 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20090215898A1 (en) * 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US8022106B2 (en) * 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
JP5205053B2 (ja) * 2004-07-30 2013-06-05 フェリング ビー．ブイ． トラネキサム酸製剤
US20060275365A1 (en) * 2005-06-07 2006-12-07 Thomas Backensfeld Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl) [4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
US20070059359A1 (en) * 2005-06-07 2007-03-15 Thomas Backensfeld Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
US20070082048A1 (en) * 2005-06-08 2007-04-12 Ronald Warner Sleep aid formulations
CA2612292C (en) 2005-06-20 2013-09-03 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
RS53624B1 (en) * 2006-03-16 2015-04-30 Euro-Celtique S.A. PHARMACEUTICAL SFEROIDS
MX2008010233A (es) * 2008-03-10 2009-11-10 Eurodrug Lab B V Composicion de liberacion modificada, que comprende doxofilina.
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
US20110184060A1 (en) * 2010-01-22 2011-07-28 Xenoport, Inc. Oral dosage forms having a high loading of a tranexamic acid prodrug
TW201132646A (en) * 2010-02-22 2011-10-01 Daiichi Sankyo Co Ltd Oral solid extended release dosage form
GB201010083D0 (en) * 2010-06-16 2010-07-21 Univ Bradford Compositions and methods
KR102286952B1 (ko) * 2013-12-31 2021-08-09 롯데정밀화학 주식회사 입도분포가 조절된 히드록시프로필 메틸셀룰로오스 아세테이트 숙시네이트(hpmcas) 입자의 제조방법 및 hpmcas 분말
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
KR20190036520A (ko) 2016-06-27 2019-04-04 아칠리온 파르마세우티칼스 인코포레이티드 의학적 장애를 치료하기 위한 퀴나졸린 및 인돌 화합물
JP2021535112A (ja) 2018-08-20 2021-12-16 アキリオン ファーマシューティカルズ，インコーポレーテッド 補体ｄ因子の医学的障害の治療のための医薬化合物
JP7504088B2 (ja) 2018-10-16 2024-06-21 ジョージア ステイト ユニバーシティー リサーチ ファウンデーション インコーポレイテッド 医学的障害の治療のための一酸化炭素プロドラッグ

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4329451A (en) * 1980-11-03 1982-05-11 The Dow Chemical Company Preparing an aqueous dispersion of colloidal size particles of a water-insoluble polysaccharide derivative
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
LU86099A1 (fr) * 1985-09-30 1987-04-02 Pharlyse Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant
CA1334379C (en) * 1987-11-24 1995-02-14 James William Mcginity Method for preparing a solid sustained release form of a functionally active composition
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US5326572A (en) * 1989-03-23 1994-07-05 Fmc Corporation Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions
EP0421582A1 (de) * 1989-10-03 1991-04-10 Warner-Lambert Company Kaubare sprühgetrocknete spheroide Mikrokapseln, polymerüberzogene Mikrokapseln und Verfahren zu ihrer Herstellung
JPH03232814A (ja) * 1990-02-08 1991-10-16 Shin Etsu Chem Co Ltd 徐放性錠剤の製造方法
JP2915590B2 (ja) * 1991-02-15 1999-07-05 第一製薬株式会社 マスクされた粒状物
KR0182801B1 (ko) * 1991-04-16 1999-05-01 아만 히데아키 고체 분산체의 제조방법
DE4244466C2 (de) * 1992-12-24 1995-02-23 Pharmatech Gmbh Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten

Also Published As

Publication number Publication date
CN1170357A (zh) 1998-01-14
CN1093758C (zh) 2002-11-06
JP3893439B2 (ja) 2007-03-14
NO320356B1 (no) 2005-11-28
EP0797987A4 (de) 1998-09-09
NO972814L (no) 1997-08-18
US5858411A (en) 1999-01-12
ATE251896T1 (de) 2003-11-15
NO972814D0 (no) 1997-06-18
FI119720B (fi) 2009-02-27
TW406022B (en) 2000-09-21
US6030644A (en) 2000-02-29
EP0797987A1 (de) 1997-10-01
WO1996019200A1 (fr) 1996-06-27
FI972622A (fi) 1997-06-18
FI972622A0 (fi) 1997-06-18
PT797987E (pt) 2004-02-27
DK0797987T3 (da) 2004-02-16
DE69531957T2 (de) 2004-08-12
EP0797987B1 (de) 2003-10-15
KR100424931B1 (ko) 2004-07-05
ES2210321T3 (es) 2004-07-01

Similar Documents

Publication Publication Date Title
DE69531957D1 (de) Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung
DE3854592D1 (de) Polyamidpulver aus Partikeln mit "Sandrose"-Struktur, Verfahren zur Herstellung des Polyamidpulvers.
DE68916048D1 (de) Verfahren zur Herstellung von monodispersen Polymerteilchen mit erhöhter Teilchengrösse.
DE69227974T2 (de) Mikrokapseln, welche anorganische Kolloiden enthalten, und Verfahren zur Herstellung
DE69509671D1 (de) Pharmazeutische zusammensetzung mit einem schmelzbaren traegermaterial und verfahren zu seiner herstellung
CA2103683A1 (en) Methods of Controlling Dust and Compositions Produced Thereby
HUT60503A (en) Process for producing 2-methyl-10-(4-methyl-1-piperazinyl)-4h-thieno/2,3-b//1,5/-benzodiazepine
DE69623869T2 (de) Verfahren zur Herstellung von Ethylen-Vinylacetatcopolymeren, verseiften Produkten aus Vinylacetatpolymeren und Harzzusammensetzungen
DE59007616D1 (de) Verfahren zur Herstellung von kugelförmigen, harten mono- oder oligodispersen Teilchen aus Melaminharz.
DE59305700D1 (de) Verfahren zur Herstellung von festen pharmazeutischen Retardformen
DE3883890D1 (de) Verfahren zur Herstellung eines Enzymgranulats.
UA26359C2 (uk) Спосіб виробhицтва граhул сечовиhи
DE59008170D1 (de) Verfahren zur Herstellung mikronisierter bioabbaubarer Partikel.
DE69625813T2 (de) Pranlukast enthaltende granula, verfahren zur herstellung der granula und verfahren zur verminderung des zusammenbackens von pranlukast
DE59309706D1 (de) Verfahren zur Herstellung kugelförmiger Granulate aus pulverförmigen Feststoffen
CA2207334A1 (en) Sustained-release granular preparations and production process thereof
FR2689876B1 (fr) Dispersions silico-acryliques, leur procédé d'obtention, leur application en stéréophotolithographie et procédé de préparation d'objets en résine.
ATE102025T1 (de) Nichtfestes augenarzneimittel und verfahren zur herstellung dieses arzneimittels.
JPS6422934A (en) Molded plastic product having roughened surface for surface treatment and production thereof
GR3018795T3 (en) Emulsion-free emulsion polymers in sustained-release pharmaceutical compositions and their production
DE3766601D1 (de) Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates.
JPS6440614A (en) Deodorizing polyester fiber
ATE119502T1 (de) Verfahren zur herstellung von agglomeriertem natriumperborat-monohydrat mit verbesserten eigenschaften.
DE68921036D1 (de) Plättchenförmige feine Oxidgemengeteilchen, hauptsächlich Ba und Fe enthaltend sowie Verfahren zur Herstellung derselben.
CA2028588A1 (en) Fixed bed fischer-tropsch catalyst and manufacture thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition